Jing Chen is Director at Biostage, Inc. (BSTG). They have made 1 open-market trade across 1 company since 2022, most recently 2022-12-07.
CIK 0001727177
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSTG | 161,468 | $37K |
Shares reported on the most recent Form 4, priced at the 2022-12-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BSTG | SELL | 2022-12-07 | 2022-12-09 | $7.17 | $696K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.